Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (271-280 of 534) with videos related to

Pageof 54
Sort By:
Virology|September 22, 2012
Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionDerseree Archary, Rong Rong, Michelle L Gordon, et al.
Aerospace Medicine and Human Performance|September 10, 2021
Adapting Disease Prevention Protocols for Human Spaceflight During COVID-19Eric Petersen, James M Pattarini, Robert A Mulcahy, et al.
Blood|April 3, 2004
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alphaMathias Lichterfeld, Xu G Yu, Michael T Waring, et al.
The Journal of Infectious Diseases|August 8, 2013
Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east AfricaRebecca N Koehler, Galit Alter, Sodsai Tovanabutra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Reply to Slogrove et alTessa Goetghebuer, Kinga K Smolen, Catherine Adler, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2018
Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income CountryTessa Goetghebuer, Kinga K Smolen, Catherine Adler, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Scientific Reports|May 14, 2024
Distinct cytokine profiles in late pregnancy in Ugandan people with HIVLisa M Bebell, Joseph Ngonzi, Audrey Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2016
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral InfectionBurton E Barnett, Ryan P Staupe, Pamela M Odorizzi, et al.
Pageof 54

Showing results (271-280 of 534) with videos related to

Sort By:
Pageof 54
Virology|September 22, 2012
Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionDerseree Archary, Rong Rong, Michelle L Gordon, et al.
Aerospace Medicine and Human Performance|September 10, 2021
Adapting Disease Prevention Protocols for Human Spaceflight During COVID-19Eric Petersen, James M Pattarini, Robert A Mulcahy, et al.
Blood|April 3, 2004
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alphaMathias Lichterfeld, Xu G Yu, Michael T Waring, et al.
The Journal of Infectious Diseases|August 8, 2013
Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east AfricaRebecca N Koehler, Galit Alter, Sodsai Tovanabutra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Reply to Slogrove et alTessa Goetghebuer, Kinga K Smolen, Catherine Adler, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2018
Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income CountryTessa Goetghebuer, Kinga K Smolen, Catherine Adler, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Scientific Reports|May 14, 2024
Distinct cytokine profiles in late pregnancy in Ugandan people with HIVLisa M Bebell, Joseph Ngonzi, Audrey Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2016
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral InfectionBurton E Barnett, Ryan P Staupe, Pamela M Odorizzi, et al.
Pageof 54